We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
376
Annexon
ANNX
$873M
$116K 0.01%
+22,602
New +$139K
HTZ icon
377
Hertz
HTZ
$998M
$114K 0.01%
+31,200
New +$113K
SVRA icon
378
Savara
SVRA
$1.17B
$112K 0.01%
36,390
+4,732
+15% +$16.5K
TRML
379
DELISTED
Tourmaline Bio
TRML
$110K 0.01%
5,437
+505
+10% +$12.7K
PACB icon
380
Pacific Biosciences
PACB
$345M
$110K 0.01%
59,988
+5,653
+10% +$11K
ALT icon
381
Altimmune
ALT
$570M
$109K 0.01%
+15,081
New +$115K
DFTX
382
Definium Therapeutics
DFTX
$5.68B
$108K 0.01%
+15,549
New +$107K
EYPT icon
383
EyePoint Inc
EYPT
$1.17B
$108K 0.01%
14,472
+4,179
+41% +$38.9K
XERS icon
384
Xeris Biopharma Holdings
XERS
$1.55B
$107K 0.01%
31,611
+2,954
+10% +$9.5K
ATXS
385
DELISTED
Astria Therapeutics
ATXS
$107K 0.01%
+11,966
New +$127K
CRMD icon
386
CorMedix
CRMD
$557M
$104K 0.01%
+12,866
New +$129K
CHPT icon
387
ChargePoint
CHPT
$166M
$102K 0.01%
4,750
– –
VERV
388
DELISTED
Verve Therapeutics
VERV
$101K 0.01%
17,952
+1,676
+10% +$9.45K
MGTX icon
389
MeiraGTx Holdings
MGTX
$1.2B
$101K 0.01%
16,571
+1,685
+11% +$9.88K
TERN
390
DELISTED
Terns Pharmaceuticals
TERN
$99.8K 0.01%
18,010
+4,475
+33% +$30.3K
AUTL
391
Autolus Therapeutics
AUTL
$564M
$99.5K 0.01%
42,345
+3,952
+10% +$13.4K
THRD
392
DELISTED
Third Harmonic Bio
THRD
$98.3K 0.01%
9,554
+1,650
+21% +$20.6K
TBPH icon
393
Theravance Biopharma
TBPH
$878M
$98.1K 0.01%
10,427
+1,018
+11% +$9.26K
ARCT icon
394
Arcturus Therapeutics
ARCT
$216M
$97.5K 0.01%
5,744
+543
+10% +$10.2K
RNAC icon
395
Cartesian Therapeutics
RNAC
$263M
$96.5K 0.01%
+5,389
New +$109K
URGN icon
396
UroGen Pharma
URGN
$2.39B
$95.3K 0.01%
8,948
+848
+10% +$10.2K
HCM icon
397
HUTCHMED
HCM
$2.13B
$94.8K 0.01%
6,577
+611
+10% +$10.9K
ALLO icon
398
Allogene Therapeutics
ALLO
$714M
$94.7K 0.01%
44,458
+4,239
+11% +$10.5K
ZVRA icon
399
Zevra Therapeutics
ZVRA
$679M
$94.4K 0.01%
+11,318
New +$96.6K
TKNO icon
400
Alpha Teknova
TKNO
$397M
$94.4K 0.01%
+11,303
New +$78.7K
14 15
16
17 18

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.